Jessicah S. Collins, Jennifer P. Beller, Christine Burt Solorzano, James T. Patrie, R. Jeffrey Chang, John C. Marshall, Christopher R.
|
|
- Maud Elliott
- 6 years ago
- Views:
Transcription
1 Supplemental Materials for manuscript entitled Blunted Day-Night Changes in Luteinizing Hormone Pulse Frequency in Girls with Obesity: the Potential Role of Hyperandrogenemia Jessicah S. Collins, Jennifer P. Beller, Christine Burt Solorzano, James T. Patrie, R. Jeffrey Chang, John C. Marshall, Christopher R. McCartney Table of Contents 1. Supplemental analyses: Day-to-night changes in mean LH and mean FSH pp. 2-5 Supplemental Figures 1 and 2 pp Supplemental analyses: Day-to-night changes in LH IPI as a function of menstrual status pp. 6-9 Supplemental Figures 3 and 4 pp
2 Supplemental analyses: Day-to-night changes in mean LH and mean FSH Previous reports have suggested that early pubertal girls with obesity or overweight demonstrate blunted nocturnal increases in gonadotropin secretion (1-3). To provide additional assessments of this phenomenon in an expanded data set, we analyzed day-to-night changes in mean LH and mean FSH. Subjects All subjects described in the main text were included in the following analyses. Statistical Analysis Mean LH and FSH concentrations during the h and 23-7 h time blocks were designated as daytime and nighttime values, respectively. ANOVA was used to assess the effects of menarcheal and obesity statuses on day-to-night changes in mean LH and mean FSH. We hypothesized that such changes are blunted in girls with obesity. Results are expressed as mean differences (nighttime values minus daytime values) with Bonferroni-corrected lower and upper 95% confidence limits. A twosided p-value.5 was utilized as the null hypothesis rejection rule. Correction for multiple comparisons was performed using the Bonferroni method; only corrected p-values are reported. Results Nonobese premenarcheal girls exhibited a significant overnight increase in mean LH (+1.72 IU/liter [+.81, +2.63]; p <.1) (Supplemental Figure 1). Obese counterparts demonstrated a nonsignificant trend in this regard (+.79 IU/liter [.23, +1.81]). Between-group differences were not statistically significant. Mean LH did not change overnight in nonobese girls (.4 IU/liter [.88, +.81]). Obese girls exhibited a non-significant overnight decrease in mean LH (.69 IU/liter [ 1.66, +.28]); the between-group comparison was not significant. Premenarcheal nonobese girls exhibited a significant overnight increase in mean FSH (+.83 IU/liter [+.39, +1.27], p <.1), but their obese counterparts did not (+.36 IU/liter [.12, +.85]) (Supplemental Figure 2). Between-group differences were not significant. Mean FSH did not change overnight in either nonobese girls (.8 IU/liter [.31, +.16]) or obese girls (.19 IU/liter [.46, +.9]); the between-group comparison was not significant. Discussion A recent study suggested that, compared to normal weight controls, overweight early pubertal girls had blunted overnight increases in both mean LH and mean FSH, although only the former was statistically demonstrable (3). Our current results support these findings. Taken together, we believe that these data provide robust evidence that early pubertal obese girls exhibit blunted sleep-related increases in serum gonadotropin concentrations. Although the recent study by Rosenfield and colleagues suggest that blunted overnight changes in mean LH relate primarily to blunted increases in LH pulse amplitude (3), our data suggest that blunted increases in LH pulse play a role as well (see primary text). We did not observe significant overnight changes in mean gonadotropin concentrations in either group. Although LH pulse decreases overnight in subjects, LH pulse amplitude increases at the same time (see primary text); this reciprocal relationship between LH pulse and LH pulse amplitude likely accounts for the absence of clear overnight changes in mean LH. Importantly, this reciprocal relationship is not a new finding. In a study of GnRH-deficient men receiving fixed doses of GnRH at varying intervals, LH pulse amplitude varied inversely with the preceding LH interpulse interval (4); this is compatible with the idea that longer intervals between GnRH pulses allow increased accumulation of LH to be released with the subsequent GnRH pulse. It is important to note that increased GnRH release per pulse may also contribute to overnight increases in LH pulse amplitude in subjects, although our data do not allow us to address this issue specifically. 2
3 References 1. McCartney CR, Prendergast KA, Blank SK, Helm KD, Chhabra S, Marshall JC 29 Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. The Journal of Clinical Endocrinology and Metabolism 94: Bordini B, Littlejohn E, Rosenfield RL 29 Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. The Journal of Clinical Endocrinology and Metabolism 94: Rosenfield RL, Bordini B, Yu C 213 Comparison of Detection of Normal Puberty in Girls by a Hormonal Sleep Test and a Gonadotropin-Releasing Hormone Agonist Test. The Journal of Clinical Endocrinology and Metabolism 98: O'Dea LS, Finkelstein JS, Schoenfeld DA, Butler JP, Crowley WF, Jr Interpulse interval of GnRH stimulation independently modulates LH secretion. The American Journal of Physiology 256:E
4 A 2 premenarcheal nonobese obese nonobese obese Mean LH (IU/liter) B Day-to-night change in mean LH (IU/liter) day night day night day night day night * a * -2 nonobese obese nonobese obese premenarcheal Supplemental Figure 1. Day-to-night changes in mean LH in peripubertal girls partitioned by menarcheal and obesity statuses. (A) Daytime (19-23 h) and nighttime (23-7 h) mean LH, with individual subject data shown as open circles and means shown as solid circles. (B) Absolute day-to-night changes in mean LH with Bonferroni-adjusted 95% confidence limits. a = Bonferroni-corrected p <.5 for day-to-night change within a group; * = Bonferroni-corrected p <.5 for comparison of day-to-night changes between groups. 4
5 A 12 premenarcheal nonobese obese nonobese obese 1 Mean FSH (IU/liter) day night day night day night day night B Day-to-night change in mean FSH (IU/liter) * a * -1. nonobese obese nonobese obese premenarcheal Supplemental Figure 2. Day-to-night changes in mean FSH in peripubertal girls partitioned by menarcheal and obesity statuses. (A) Daytime (19-23 h) and nighttime (23-7 h) mean FSH, with individual subject data shown as open circles and means shown as solid circles. (B) Absolute day-to-night changes in mean FSH with Bonferroni-adjusted 95% confidence limits. a = Bonferroni-corrected p <.5 for day-to-night change within a group; * = Bonferroni-corrected p <.5 for comparison of day-to-night changes between groups. 5
6 Supplemental analyses: Day-to-night changes in LH IPI as a function of time since most recent menses Sleep-related slowing of LH (GnRH) pulse during the early follicular phase is well described (1-7). Studies also suggest that late follicular LH pulse in women slows by 2-3% during sleep (8-1). Of interest, some studies suggest that the gradual increase in 24-h LH across the follicular phase is primarily related to a gradual increase in sleep-related but not waking LH pulse (i.e., a gradual reduction in nocturnal LH slowing) (2, 5). It is possible that an increase in sleep-associated LH pulse across the follicular phase and hence the less marked overnight slowing of LH pulse in the late follicular phase compared to the early follicular phase reflects a gradual waning of progesterone s effect to slow (nocturnal) LH pulse (11). Anovulatory women with PCOS do not appear to exhibit nocturnal decreases in LH pulse (12), and length of time since the last luteal phase may help explain this finding. Since some subjects in the current study were evaluated on cycle days 8-1 and others were evaluated at least 6 days after most recent menses, length of time since the most recent luteal phase (with cycle day being a surrogate marker) could be a potential confounder in our analysis. To assess this possibility, we performed additional analyses in subjects. Subjects The majority of subjects described in the main text were included in the following analyses. Specific cycle day was unavailable for two subjects with obesity and hyperandrogenemia (HA) studied at UCSD; these subjects were thus omitted from these analyses. Statistical Analysis Day-to-night change in LH IPI was calculated as nighttime (23-7 h) IPI minus daytime (19-23 h) IPI. Thus, positive and negative values represent day-to-night decreases and increases, respectively, in LH pulse. As an initial analysis, day-to-night IPI changes were compared between 39 girls with recent menses (cycle day 8-1) and 22 girls without recent menses (cycle day 6). Then, day-to-night IPI changes were compared between obese girls with (n = 8) and without (n = 17) recent menses. All pairwise comparisons were performed using the Wilcoxon rank sum test, a non-parametric test that is based on ranks of observations and require no assumptions about the underlying distribution of data. The method of normal approximation was used for pairwise comparisons involving at least 1 observations per group; otherwise, exact Wilcoxon tests were employed. Given that the above analyses suggested that cycle day could be a potential confounder regarding the impact of HA on day-night LH pulse changes in obese girls, day-to-night changes in LH IPI were more formally analyzed by way of two-way ANOVA. The dependent variable was day-to-night change in log e (LH IPI), and the two ANOVA factors were HA status and menstrual status (i.e., whether or not the subject had experienced recent menses). This allowed a comparison of daynight LH pulse changes among 4 obese subgroups: (1) non-ha with recent menses (n = 5), (2) HA with recent menses (n = 3), (3) non-ha without recent menses (n = 4), (4) HA without recent menses (n = 13). Lastly, multiple linear regression was performed in subjects to independently assess predictors of (a) daytime (19-23 h) LH IPI (model 1) and (b) nighttime (23-7 h) LH IPI (model 2). For these models, predictor variables included age, BMI z-score, free testosterone concentration, and cycle day. The regression models were estimated via ordinary least squares, and restricted-cubic-spline functions of the predictor variables were utilized to assess non-linear trends. Conventional F-tests were employed to test for predictor variable versus outcome variable association. For all tests, a two-sided p-value.5 was utilized as the null hypothesis rejection rule. Adjustment for multiple pairwise comparisons was performed as necessary using the Bonferroni method; only corrected p-values are reported. 6
7 Results Wilcoxon rank sum tests When considering all subjects, subjects with recent menses had more marked day-to-night decreases in LH pulse compared to subjects without recent menses (mean ± standard deviation [median] IPI increase of 42.6 ± 37.8 [31.] vs. 7.3 ± 21.9 [1.] minutes; p <.1) (Supplemental Figure 3A). However, those without recent menses were also more obese (BMI z-scores 2.1 ±.5 [2.2] vs..9 ±.9 [1.], p <.1) and had 2.7-fold higher free testosterone concentrations (42.1 ± 22.8 [43.] vs ± 13. [1.] pmol/liter; p <.1). When considering only obese subjects, those with and without recent menses did not demonstrate a statistically significant difference of day-to-night decrease in LH pulse (IPI increases of 26.4 ± 41. [11.] vs. 8.1 ± 23.3 [8.8] minutes, respectively; p = 1.) (Supplemental Figure 3A). Although BMI z-scores were similar (2.2 ±.3 [2.2] vs. 2.3 ±.3 [2.4]), free testosterone concentrations were 8% higher in those without recent menses (26.5 ± 17.8 [19.6] vs ± 22.6 [46.3] pmol/liter; p =.48). Although the above analysis suggested that cycle day may be an important predictor of day-tonight decrease in LH pulse, it is of interest that nearly identical results were obtained when comparing day-to-night changes in LH pulse between subjects with and without HA (p <.1 by the Wilcoxon rank sum test) (Supplemental Figure 3B). This is not particularly surprising given that oligomenorrhea and HA tended to coexist among our cohort of obese girls; among such girls, the Spearman rank (non-parametric) correlation between cycle day and free testosterone concentration was high (r =.61, p =.1). Two-way ANOVA The non-ha subgroup with recent menses exhibited a day-to-night decrease in LH pulse (IPI change: +33%, 95% CI [+7, +51%]; p =.18), but day-night LH pulse changes were not demonstrable in any other subgroup (Supplemental Figure 4). There was no association between day-to-night changes in LH pulse and either HA status (p =.492) or menstrual status (p =.663). Multiple linear regression analyses Multiple linear regression model 1 was not predictive of daytime LH IPI (p =.133). Free testosterone appeared to be a unique predictor of daytime LH IPI (p =.34), but none of the other variables were (BMI z-score, p =.42; age, p =.568; cycle day, p =.727). Multiple linear regression model 2 was predictive of nighttime LH IPI (p =.7, adjusted R 2 =.2), although none of the independent variables were unique predictors of nighttime LH IPI (free testosterone, p =.285; age, p =.33; BMI z-score, p =.499; cycle day, p =.56). Discussion The above supplemental analyses suggest that cycle day may be an important predictor of nocturnal LH pulse slowing among subjects. Thus, although our data suggest that day-to-night changes in LH pulse are altered in obese girls, firm conclusions regarding whether this finding relates to HA vs. menstrual status (possibly remoteness from progesterone exposure) vs. some other factor related to obesity are difficult because these factors frequently coexisted in our cohort of girls. However, these supplementary analyses do not provide evidence that the presence or absence of recent menses is a more important determinant of nocturnal LH pulse slowing compared to HA. For example, among obese subjects with HA, day-night changes appeared to be identical between those with and without recent menses (Supplemental Figure 4). Also of interest, among obese girls with recent menses, our data suggest the possibility of less overnight LH pulse slowing in girls with HA compared to those 7
8 without. A similar consideration pertains to girls without recent menses, although apparent differences were less prominent. Importantly, our analyses were likely inadequately powered in this regard, preventing us from making firm conclusions. One may hypothesize that the degree of nocturnal LH pulse slowing during the follicular phase is partly determined by the length of time since most recent exposure to luteal progesterone levels. This notion could help explain why anovulatory women with PCOS do not exhibit nocturnal decreases in LH pulse (12). A study by Taylor and colleagues (13) also provides data that are consistent with this idea: compared to anovulatory women with PCOS, recently post-ovulatory women with PCOS had significantly lower pool LH, lower pool LH-to-FSH ratio, and fewer LH pulses over 24-h (8 vs. 18 pulses). However, nocturnal changes in LH secretion were not assessed in that particular study. Importantly, when assessing the effects of ovulatory status on nocturnal LH pulse slowing, testosterone concentrations represent an important potential confounder. While normal women exhibit nocturnal slowing of LH pulse during the follicular phase and anovulatory women with PCOS may not, androgen concentrations are also different between normal follicular controls and women with PCOS. Similarly, in the aforementioned study by Taylor et al (13), post-ovulatory women with PCOS had significantly lower testosterone concentrations compared to anovulatory women with PCOS (.8 vs. 1.3 ng/ml). Lastly, among our subjects, cycle day (ovulatory status) correlated strongly with free testosterone concentrations (HA status). Thus, we were unable to separate the influence of these two characteristics in a reliable fashion. In conclusion, ovulatory status (recently post-ovulatory vs. anovulatory) may be an important predictor of nocturnal LH pulse slowing among obese subjects and is thus a potential confounder in our primary analysis. However, we are unaware of data that clearly confirms this hypothesis. We propose that this is an important topic for future research. References 1. Soules MR, Steiner RA, Cohen NL, Bremner WJ, Clifton DK 1985 Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle. The Journal of Clinical Endocrinology and Metabolism 61: Filicori M, Santoro N, Merriam GR, Crowley WF, Jr Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. The Journal of Clinical Endocrinology and Metabolism 62: Rossmanith WG, Yen SS 1987 Sleep-associated decrease in luteinizing hormone pulse during the early follicular phase of the menstrual cycle: evidence for an opioidergic mechanism. The Journal of Clinical Endocrinology and Metabolism 65: Loucks AB, Mortola JF, Girton L, Yen SS 1989 Alterations in the hypothalamic-pituitaryovarian and the hypothalamic-pituitary-adrenal axes in athletic women. The Journal of Clinical Endocrinology and Metabolism 68: Rossmanith WG, Liu CH, Laughlin GA, Mortola JF, Suh BY, Yen SS 199 Relative changes in LH pulsatility during the menstrual cycle: using data from hypogonadal women as a reference point. Clinical Endocrinology 32: Rossmanith WG, Lauritzen C 1991 The luteinizing hormone pulsatile secretion: diurnal excursions in normally cycling and postmenopausal women. Gynecological Endocrinology 5: Hall JE, Sullivan JP, Richardson GS 25 Brief wake episodes modulate sleep-inhibited luteinizing hormone secretion in the early follicular phase. The Journal of Clinical Endocrinology and Metabolism 9: Loucks AB, Heath EM 1994 Dietary restriction reduces luteinizing hormone (LH) pulse during waking hours and increases LH pulse amplitude during sleep in young menstruating women. The Journal of Clinical Endocrinology and Metabolism 78:
9 9. Loucks AB, Thuma JR 23 Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. The Journal of Clinical Endocrinology and Metabolism 88: McCartney CR, Blank SK, Marshall JC 27 Progesterone acutely increases LH pulse amplitude but does not acutely influence nocturnal LH pulse slowing during the late follicular phase in women. American Journal of Physiology Endocrinology and Metabolism 292:E McCartney CR, Gingrich MB, Hu Y, Evans WS, Marshall JC 22 Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse during the follicular phase reflects the gradual loss of the restraining effects of progesterone. The Journal of Clinical Endocrinology and Metabolism 87: Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF, Jr Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. The Journal of Clinical Endocrinology and Metabolism 66: Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE 1997 Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 82:
10 A 16 all subjects only obese subjects all subjects * * B 16 only obese subjects Day-to-night change in IPI (minutes) decrease increase decrease increase -6 with recent menses without recent menses with recent menses without recent menses -6 with HA without HA with HA without HA Supplemental Figure 3. (A) Day-to-night changes in LH interpulse interval (IPI) in subjects stratified by menstrual status. (B) Day-to-night changes in LH IPI in subjects stratified by hyperandrogenemia (HA) status. Day-to-night IPI change was calculated as nighttime (23-7 h) IPI minus daytime (19-23 h) IPI. Thus, positive and negative values represent day-to-night decreases and increases, respectively, in LH pulse. * = Bonferroni-corrected p <.1 by Wilcoxon rank sum test. 1
11 75 Percent day-to-night change in GM LH IPI decrease increase a -5 non-ha HA non-ha HA obese with recent menses obese without recent menses Supplemental Figure 4. Day-to-night changes in LH pulse in girls partitioned by menstrual status (presence or absence of recent menses) and hyperandrogenemia (HA) status. Changes in LH pulse are expressed as percent change in geometric mean (GM) interpulse interval (IPI) with Bonferroni-adjusted 95% confidence limits. Day-to-night increases in GM IPI represent decreases in pulse and vice versa. a = Bonferroni-corrected p <.5 for day-to-night change within a group. 11
Progesterone administration does not acutely alter LH pulse secretion in the mid-follicular phase in women
ORIGINAL RESEARCH Physiological Reports ISSN 51-817X Progesterone administration does not acutely alter LH pulse secretion in the mid-follicular phase in women Su Hee Kim 1,, Christine M. Burt Solorzano,3
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationHyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion
DOI: 10.1111/j.1471-0528.2009.02383.x www.bjog.org Commentary Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion CM Burt Solorzano, a,b CR McCartney, b,c
More informationThe role of changing pulse frequency in the regulation of ovulation
Human Reproduction vol.8 Suppl.2 pp.57-61, 1993 The role of changing pulse frequency in the regulation of ovulation J.C.Marshall 1 and M.L.Griffin Division of Endocrinology and Metabolism, Department of
More informationReproductive FSH. Analyte Information
Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationIMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS
IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of
More information1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH.
1. During the follicular phase of the ovarian cycle, the hypothalamus releases GnRH. 2. This causes the anterior pituitary to secrete small quantities of FSH and LH. 3. At this time, the follicles in the
More informationSummary
Summary 118 This thesis is focused on the background of elevated levels of FSH in the early follicular phase of women with regular menstrual cycles. In the introduction (chapter 1) we describe the characteristics
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationReproductive Hormones
Reproductive Hormones Male gonads: testes produce male sex cells! sperm Female gonads: ovaries produce female sex cells! ovum The union of male and female sex cells during fertilization produces a zygote
More informationDOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS
DOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS D R. G A N A P A T H I. B D E P T. O F E N D O C R I N O L O G Y S T. J O H N S M E D I C A L C O
More informationHormonal Control of Human Reproduction
Hormonal Control of Human Reproduction Bởi: OpenStaxCollege The human male and female reproductive cycles are controlled by the interaction of hormones from the hypothalamus and anterior pituitary with
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More informationThe reproductive lifespan
The reproductive lifespan Reproductive potential Ovarian cycles Pregnancy Lactation Male Female Puberty Menopause Age Menstruation is an external indicator of ovarian events controlled by the hypothalamicpituitary
More informationCynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital
Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More information10.7 The Reproductive Hormones
10.7 The Reproductive Hormones December 10, 2013. Website survey?? QUESTION: Who is more complicated: men or women? The Female Reproductive System ovaries: produce gametes (eggs) produce estrogen (steroid
More informationTRHC.UEMEE Ph P y h si s o i logy l of fmen M str st u r at a i t on i
. TRHCUEMEE Physiology of Menstruation Learning objectives: By the end of this lecture the students should be able to: Define menstruation. List the Characters of normal menstruation Enumerate Components
More informationReproductive hormones and epilepsy
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 7 Treatment of women with epilepsy - Level 1-2 Reproductive hormones and epilepsy Gerhard
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationReproductive cyclicity 19. Introduction. Page 1. repro and its story lines. Male repro: a simpler way of control
Reproductive cyclicity 19 Male repro: a simpler way of control Menstrual cycles: ovary / uterine anatomy and cell types, follicular phase, ovulation, luteal phase, cyclicity Race events: removal of P4
More informationChapter-IV. Blood pressure and heart rate variability as function of ovarian cycle in young women
Blood pressure and heart rate variability as function of ovarian cycle in young women INTRODUCTION In human females, the menstrual cycle begins with the onset of menstrual flow on day 1. The menstrual
More informationWhy is my body not changing? Conflicts of interest. Overview 11/9/2015. None
Why is my body not changing? Murthy Korada Pediatrician, Pediatric Endocrinologist Ridge Meadows Hospital Surrey Memorial Hospital None Conflicts of interest Overview Overview of normal pubertal timing
More informationMonth-Long Hormone Assessment: What goes up must come down. Disclaimer. Aims and Objectives. George Gillson MD PhD
Month-Long Hormone Assessment: What goes up must come down George Gillson MD PhD 1 Disclaimer The information presented in this Webinar is the opinion of Dr. Gillson based on his research and experience.
More informationT. B. NIPPOLDT, S. KHOURY, A. BARKAN, R. P. KELCH AND J. C. MARSHALL
Clinical Endocrinology (1987), 26,293-30 1 GONADOTROPHIN RESPONSES TO GnRH PULSES IN HYPOGONADOTROPHIC HYPOGONADISM: LH RESPONSIVENESS IS MAINTAINED IN THE PRESENCE OF LUTEAL PHASE CONCENTRATIONS OF OESTROGEN
More informationPubertal Development in Japanese Boys
Clin Pediatr Endocrinol 1993; (SuPP13): 7-14 Copyright (C)1993 by The Japanese Society for Pediatric Endocrinology Pubertal Development in Japanese Boys Kenji Fujieda, M.D., Ph. D. Department of Pediatrics,
More informationChapter 14 Reproduction Review Assignment
Date: Mark: _/45 Chapter 14 Reproduction Review Assignment Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Use the diagram above to answer the next question.
More informationFemale Reproductive System. Lesson 10
Female Reproductive System Lesson 10 Learning Goals 1. What are the five hormones involved in the female reproductive system? 2. Understand the four phases of the menstrual cycle. Human Reproductive System
More informationPolycystic Ovary Syndrome
What is the polycystic ovary syndrome? Polycystic Ovary Syndrome The polycystic ovary syndrome (PCOS) is a clinical diagnosis characterized by the presence of two or more of the following features: irregular
More informationThe reproductive system
The reproductive system THE OVARIAN CYCLE HORMONAL REGULATION OF OOGENSIS AND OVULATION hypothalamic-pituitary-ovary axis Overview of the structures of the endocrine system Principal functions of the
More information2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: Name of Study Drug: Volume: Abbott-43818 (ABT-818) leuprolide acetate for depot suspension (Lupron Depot ) Name of
More informationSERUM AUTOANTIBODIES DIRECTED TO THE GONADOTROPIN RELEASING HORMONE RECEPTOR ECL2 ARE DIAGNOSTIC OF PCOS
SERUM AUTOANTIBODIES DIRECTED TO THE GONADOTROPIN RELEASING HORMONE RECEPTOR ECL2 ARE DIAGNOSTIC OF PCOS PRESENTED BY MYRIAM ELKOSSEIFI,MD PGY5 OKLAHOMA UNIVERSITY HEALTH SCIENCES CENTER AND OKC-VAMC I
More informationRelation of luteinizing hormone levels to body mass index in premenopausal women
FERTILITY AND STERILITY VOL. 69, NO. 3, MARCH 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Relation of luteinizing
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationLH, luteinizing hormone
003 1-3998/86/2007-0632$02.00/0 PEDIATRIC RESEARCH Copyright O 1986 International Pediatric Research Foundation, Inc Vol. 20, No. 7, 1986 Printed in U.S.A. Appraising Endocrine Pulse Signals at Low Circulating
More informationPrevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study
Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Mousa Mohsen Ali* Wasan Ghazi* HayderAamerAbboud^ *Kerbala University, College of Medicine, Gynecology
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Puberty and Pubertal Disorders Part 2: Precocious Puberty. These podcasts are designed to give medical students an overview
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationEndocrine control of female reproductive function
Medicine School of Women s & Children s Health Discipline of Obstetrics & Gynaecology Endocrine control of female reproductive function Kirsty Walters, PhD Fertility Research Centre, School of Women s
More informationFollicle profile and plasma gonadotropin concentration in pubertal female ponies
Brazilian Journal of Medical and Biological Research (0) 37: 913-9 Puberty in female pony ISSN 00-79X 913 Follicle profile and plasma gonadotropin concentration in pubertal female ponies Departamento de
More informationEFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY. Department OB/GYN. EVMA Norfolk, Va Telephone: (804)
This study predates but predicts the use of glucophage, exercise and diet for the treatment of PCO. EFFECT OF WEIGHT LOSS ON OVARIAN AND ADRENAL ANDROGEN SENSITIVITY Principal Investigator: Hofheimer Hall
More informationManagement of Adolescent Hyperandrogenism
Management of Adolescent Hyperandrogenism 4 Charles Sultan, Laura Gaspari, and Françoise Paris 4.1 Introduction Androgen excess during puberty produces a variety of clinical signs and symptoms that must
More informationChapter 28: REPRODUCTIVE SYSTEM: MALE
Chapter 28: REPRODUCTIVE SYSTEM: MALE I. FUNCTIONAL ANATOMY (Fig. 28.1) A. Testes: glands which produce male gametes, as well as glands producing testosterone 2. Seminiferous tubules (Fig.28.3; 28.5) a.
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationInvestigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle?
Investigation: The Human Menstrual Cycle Research Question: How do hormones control the menstrual cycle? Introduction: The menstrual cycle (changes within the uterus) is an approximately 28-day cycle that
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationStudy of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population
Original article: Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population 1Dr Shalini Kanotra, 2 Dr Nikita Singh*, 3 Dr V B Bangal 1 Associate Professor, OBGY Department,
More informationTwo important cells in female are the theca cells and the granulose cells. Granulosa cells are affected by the two gonadotropin hormones; FSH and LH.
1 UGS physiology sheet #13 lecture 3 Dr.Saleem Khresha. Now we will start discussing the female reproductive system Ovarian Steroids Two important cells in female are the theca cells and the granulose
More informationclinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome
& clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome Zulfo Godinjak¹*, Ranka Javorić² 1 Gynecology and Obstetrics
More information9.4 Regulating the Reproductive System
9.4 Regulating the Reproductive System The Reproductive System to unite a single reproductive cell from a female with a single reproductive cell from a male Both male and female reproductive systems include
More informationReproduction. Introduction
Reproduction The goal of these lectures is to discuss basic physiology associated with the control of reproduction (from sexual diferentiation to adult reproductive function). 26 The sections for this
More informationLab Guide Endocrine Section Lab Guide
Lab Guide - 2019 Endocrine Section Lab Guide Estradiol Estradiol, Cerner Name: Estradiol Competitive test principle using a polyclonal antibody specifically directed against 17βestradiol in Roche Cobas
More informationDiagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome
Endocrine Journal 2007, 54 (2), 233 238 Diagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome TAKESHI IWASA, TOSHIYA MATSUZAKI, MASAHIRO MINAKUCHI, NAOKO
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationMenstrual Cycle. Last example of how a circle works. Course Outline. Topic #! Topic lecture! Silverthorn! Membranes (pre-requisite material)!!
The goal of these lectures is to discuss how control system is formed and operates. For this, basic physiology associated with the control the menstrual cycle will be used. The sections for this lecture
More informationEndocrinologic features of oligomenorrheic adolescent girls*
FERTILITY AND STERILITY Copyright 1986 The American Fertility Society Printed in U.SA. Endocrinologic features of oligomenorrheic adolescent girls* Rita Siegberg, M.D. t Carl Gustaf Nilsson, M.D. Ulf-Hakan
More informationwww.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc Conflict of interest none Outline Causes of ovulatory dysfunction Assessment of women with ovulatory dysfunction Management First line Second
More informationCARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME
CARDIOVASCULAR EVENTS IN POLYCYSTIC OVARY SYNDROME Enrico Carmina Executive Director & CEO of Androgen Excess & PCOS Society Professor of Endocrinology Department of Health Sciences and Mother and Child
More informationHCG (human chorionic gonadotropin); Novarel Pregnyl (chorionic gonadotropin); Ovidrel (choriogonadotropin alfa)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.08.09 Subject: HCG Page: 1 of 5 Last Review Date: June 19, 2015 HCG Powder, Novarel, Pregnyl, Ovidrel
More informationPolycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners. M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017
Polycystic Ovarian Syndrome and Obstructive Sleep Apnea: Poor Bedpartners M. Begay, MD UNM Sleep Medicine Fellow 01/31/2017 Case of S.R. S.R. is a 39 year old female referred for suspected obstructive
More informationMULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure.
Chapter 27 Exam Due NLT Thursday, July 31, 2015 Name MULTIPLE CHOICE: match the term(s) or description with the appropriate letter of the structure. Figure 27.1 Using Figure 27.1, match the following:
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationClinical Study LH Dynamics in Overweight Girls with Premature Adrenarche and Slowly Progressive Sexual Precocity
Hindawi Publishing Corporation International Journal of Pediatric Endocrinology Volume 2010, Article ID 724696, 12 pages doi:10.1155/2010/724696 Clinical Study LH Dynamics in Overweight Girls with Premature
More informationPolycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology
Polycystic Ovarian Syndrome Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology Outline Definition Symptoms Causal factors Diagnosis Complications Treatment Why are we talking about
More informationChapter-V. Summary, Conclusions and Recommendations
Summary, Conclusions and Recommendations INTRODUCTION The work included in this thesis entitled, Circadian heart rate and blood pressure variability in apparently healthy subjects using ABPM has been divided
More informationScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
Endocr Rev. 2015 Oct; 36(5): 487 525. doi: 10.1210/er.2015-1018 PMCID: PMC4591526 Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary
More informationCan Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?
www.ijpm.in www.ijpm.ir Can Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome? Ferdous Mehrabian, Maryam Afghahi Department
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationMICROWELL ELISA LUTEINIZING HORMONE (LH) ENZYMEIMMUNOASSAY TEST KIT LH ELISA. Cat # 4225Z
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationStage 4 - Ovarian Cancer Symptoms
WELCOME Stage 4 - Ovarian Cancer Symptoms University of Baghdad College of Nursing Department of Basic Medical Sciences Overview of Anatomy and Physioloy II Second Year Students Asaad Ismail Ahmad,
More informationReproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationTHE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY
THE MENSTRUAL CYCLE INA S. IRABON, MD, FPOGS, FPSRM, FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY REFERENCE Comprehensive Gynecology 7 th edition, 2017 (Lobo RA, Gershenson
More informationEffect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome
FERTILITY AND STERILITY VOL. 71, NO. 2, FEBRUARY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effect of troglitazone
More informationAnimal Reproduction. Reproductive Cyclicity. # lectures for cumulative test # 02 book 12. Reproductive cyclicity: terminology and basic concepts
Animal Reproduction JP Advis DVM, Ph.D. Bartlett Hall, Animal Sciences, Cook, (732) 932-9240, advis@aesop.rutgers.edu 15 Course website: rci.rutgers.edu/~advis Material to be covered: About lecture Meetings
More information696 Biomed Environ Sci, 2015; 28(9):
696 Biomed Environ Sci, 2015; 28(9): 696-700 Letter to the Editor Fluoride Exposure, Follicle Stimulating Hormone Receptor Gene Polymorphism and Hypothalamus-pituitary-ovarian Axis Hormones in Chinese
More informationLaura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia
Precocious Puberty Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia Faculty Disclosure Faculty: Laura Stewart No relationships with
More informationDiagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies
Diagnosis and Management of Polycystic Ovary Syndrome During Adolescence: Questions and Controversies 2017 Illinois-AACE 2017 Annual Meeting October 14, 2017 Learning Objectives 1) Understand the challenges
More informationTest Briefing on Hormonal Disorders and Infertility
Test Briefing on Hormonal Disorders and Infertility Test Briefing on Hormonal Disorders Common Tests FSH LH Progesterone Estradiol Prolactin Testosterone AFP AMH PCOS Panel FSH (Follicle Stimulating Hormone)
More informationREPRODUCTION & GENETICS. Hormones
REPRODUCTION & GENETICS Hormones http://www.youtube.com/watch?v=np0wfu_mgzo Objectives 2 Define what hormones are; Compare and contrast the male and female hormones; Explain what each hormone in the mail
More informationReproductive physiology. About this Chapter. Case introduction. The brain directs reproduction 2010/6/29. The Male Reproductive System
Section Ⅻ Reproductive physiology Ming-jie Wang E-Mail: mjwang@shmu.edu.cn About this Chapter The reproductive organs and how they work the major endocrine functions of sexual glands actions of sex hormones
More informationThe study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi
The study of correlation between BMI and infertility Dr. seyed mohammadreza fouladi Female Infertility Infertility is a generally defined as one year unprotected intercourse without contraception. Approximately
More informationThe Pennsylvania State University. The Graduate School. College of Health and Human Development THE ROLE OF LEPTIN IN THE ETIOLOGY OF
The Pennsylvania State University The Graduate School College of Health and Human Development THE ROLE OF LEPTIN IN THE ETIOLOGY OF EXERCISE-ASSOCIATED MENSTRUAL DISTURBANCES A Thesis in Kinesiology by
More informationReproduction. Inhibin B. Analyte Information
Reproduction Inhibin B Analyte Information - 1-2011-01-11 Inhibin B Introduction Inhibins are polypeptides belonging to the transforming growth factor-β (TGF-β) superfamily which also includes TGF-β, activin
More informationN. Shirazian, MD. Endocrinologist
N. Shirazian, MD Internist, Endocrinologist Inside the ovary Day 15-28: empty pyfollicle turns into corpus luteum (yellow body) Immature eggs Day 1-13: 13: egg developing inside the growing follicle Day
More informationPage 1. A wide variety of ovarian abnormalities are encountered in clinical practice
A wide variety of ovarian abnormalities are encountered in clinical practice Common Problems Anovulatory follicles Persistent anovulatory follicles Hemorrhagic/Luteinized follicles Persistent corpus luteum
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69 Effect of Metformin Only versus Effect of Metformin and Corticosteroids after Laparoscopic Ovarian Drilling on Ovulation
More informationRelationship of nighttime arousals and nocturnal cortisol in IBS and normal subjects. Miranda Bradford. A thesis submitted in partial fulfillment
Relationship of nighttime arousals and nocturnal cortisol in IBS and normal subjects Miranda Bradford A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University
More informationFemale Reproductive System. Justin D. Vidal
Female Reproductive System Justin D. Vidal If you cannot identify the tissue, then it is probably part of the female reproductive system! Introduction The female reproductive system is constantly changing,
More informationUltrasound of Uterus and Ovary
1 of 16 5/3/2005 8:34 PM Contents: Ultrasound of Uterus and Ovary Introduction Section 1: The Normal Ovary by Ultrasound Section 2: Ultrasound of Normal Ovarian Follicular Cycles Section 3: Ultrasound
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationReproduction and Development. Female Reproductive System
Reproduction and Development Female Reproductive System Outcomes 5. Identify the structures in the human female reproductive system and describe their functions. Ovaries, Fallopian tubes, Uterus, Endometrium,
More informationProf. Dr. Abha Majumdar Director, Center of IVF and Human Reproduction Sir Ganga Ram Hospital, New Delhi, INDIA
Prof. Dr. Abha Majumdar Director, Center of IVF and Human Reproduction Sir Ganga Ram Hospital, New Delhi, INDIA President s Medal for best medical graduate 1970-75 Dr. B.C Roy s award 1999 for outstanding
More informationCASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology
CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology A 49-year-old woman complains of irregular menses over the past 6 months, feelings of inadequacy, vaginal dryness, difficulty sleeping, and episodes
More informationSomnological Aspects of Puberty
Puberty Somnological Aspects of Puberty JMAJ (3): 11 1, 005 Kiyohisa TAKAHASHI President, Aino University Abstract: The characteristics of sleep during puberty are discussed from the physiological aspect
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationAMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE Formerly The American Fertility Society OVULATION DETECTION A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive
More informationGonadotropin-releasing hormone (GnRH) analog depot preparations have now been in use for more than 15 years and
REPRODUCTIVE OUTCOME IN PATIENTS TREATED AND NOT TREATED FOR IDIOPATHIC EARLY PUBERTY: LONG-TERM RESULTS OF A RANDOMIZED TRIAL IN ADULTS ALESSANDRA CASSIO, MD, MILVA O. BAL, MD, LUIGI F. ORSINI, MD, ANTONIO
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More information